In March, FDA announced a transition plan for certain COVID-19-related steerage documents related to matters corresponding to medical gadgets, scientific apply and supply chains, including which policies will end or be temporarily prolonged. To learn more, please visit FDA’s COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other Stakeholders. Based on current COVID-19 developments, theRead more
Comentarios recientes